Hydrochloric Acid → N-(2-Fluoro-5-(2-(4-methylpiperazin-1-yl)benzylcarbamoyl)phenyl)-7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide Hydrochloride
Reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8](=[O:24])[NH:9][CH2:10][C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=2[N:17]2[CH2:22][CH2:21][N:20]([CH3:23])[CH2:19][CH2:18]2)=[CH:4][C:3]=1[NH:25][C:26]([C:28]1[N:32]2[CH:33]=[CH:34][C:35]([C:37]3[CH:38]=[N:39][N:40]([CH3:42])[CH:41]=3)=[CH:36][C:31]2=[N:30][CH:29]=1)=[O:27].[ClH:43].CCOCC>CO>[ClH:43].[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8](=[O:24])[NH:9][CH2:10][C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=2[N:17]2[CH2:18][CH2:19][N:20]([CH3:23])[CH2:21][CH2:22]2)=[CH:4][C:3]=1[NH:25][C:26]([C:28]1[N:32]2[CH:33]=[CH:34][C:35]([C:37]3[CH:38]=[N:39][N:40]([CH3:42])[CH:41]=3)=[CH:36][C:31]2=[N:30][CH:29]=1)=[O:27]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
N-(2-Fluoro-5-(2-(4-methylpiperazin-1-yl)benzylcarbamoyl)phenyl)-7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide (step 1) (30 mg, 0.053 mmol) in MeOH (2 ml) was treated with HCl in ether (0.053 ml, 0.053 mmol) and the solution was evaporated to dryness and dried in vacuo overnight to afford the title compound; LC-MS: Rt 0.82 mins; MS m/z 56, [M+H]+; Method 2minLC_v003
Workup
- customthe solution was evaporated to dryness
- customdried in vacuo overnight
Sources & evidence
- ORD record
- ord-573141bdfa3a46c8acb57a6be854b3f4
- Source dataset
- uspto-grants-2014_11
- Patent number
- US08883819B2
Reaction notes
Loading…